InvestorsHub Logo
Followers 59
Posts 3816
Boards Moderated 0
Alias Born 05/25/2021

Re: HyGro post# 519071

Tuesday, 10/04/2022 5:20:41 PM

Tuesday, October 04, 2022 5:20:41 PM

Post# of 698555
Do you really believe "BP is far better at designing and executing trials."? If you do, that certainly doesn't bode well for NVCR.

Here is a trial sponsored by Bristol-Myers Squibb and NovoCure.

https://clinicaltrials.gov/ct2/show/NCT03430791?cond=glioblastoma+++Opdivo&draw=2&rank=5

But the trial was terminated last year because BP is far better not only designing and executing trials but telling the good trials from the bad ones.

Now the trial solo sponsored by NVCR is almost predictable.

https://clinicaltrials.gov/ct2/show/NCT03405792?cond=Glioblastoma+%2B+Pembrolizumab&draw=4&rank=11

Good luck to you.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News